Summary
Highlights
Dr. Lorena Rea introduces the topic of ADHD and anxiety, noting their prevalence in psychiatric practice and among young adults. She outlines the presentation's structure, covering definitions, diagnostic criteria, neurobiology, treatment options, and distinguishing facts from misinformation for both conditions.
Dr. Rea explains ADHD, defining it as Attention Deficit Hyperactivity Disorder, and detailing its three types: predominantly inattentive, predominantly hyperactive-impulsive, and combined presentation. She clarifies that 'ADD' is an outdated term. A key diagnostic criterion discussed is that symptoms must be present before age 12 and in at least two different settings. She highlights how social media often misrepresents ADHD, cautioning against self-diagnosis based on common experiences.
Dr. Rea clarifies that ADHD is not as common as social media suggests, with 7.2% of children worldwide and 2-6% of US adults affected. She then delves into the inattentive type, illustrating symptoms like careless mistakes, difficulty sustaining attention, not listening when spoken to, failure to follow through on tasks, organizational challenges, and frequent loss of items. She emphasizes that these are frequent, persistent patterns, not isolated incidents.
This section details the hyperactive-impulsive presentation of ADHD, characterizing affected individuals as 'Energizer Bunnies.' Symptoms include fidgeting, getting up from seats, running around excessively, difficulty playing quietly, being 'on the go,' excessive talking, difficulty waiting turns, and interrupting others. These behaviors are often perceived as rude or problematic, but stem from genuine hyperactivity and impulsivity.
Dr. Rea addresses common comments heard in practice, such as children being 'all over the place' or 'not very bright,' and the self-esteem issues faced by individuals with ADHD. She debunks the myth that smart people can't have ADHD, noting they often compensate well, leading to underdiagnosis. She also touches on fear of medication and the significant impact ADHD can have on social interactions and job stability, explaining the 'I saw it on TikTok' phenomenon.
Dr. Rea provides additional facts about ADHD: it's highly genetic, linked to prenatal smoking, and often associated with emotional dysregulation, conduct issues, and learning disorders. She explains that ADHD increases the risk for mood, anxiety, and substance use disorders, but effective treatment reduces these risks. She also notes that hyperactivity tends to improve with age, but inattention persists. Neurobiologically, ADHD involves impaired signaling in the prefrontal cortex due to lower levels of norepinephrine and dopamine, leading to reduced signal strength and increased distraction. Brain volume differences and developmental delays in maturation are also observed.
Dr. Rea advises those suspecting ADHD to seek professional evaluation, often involving psychological or neuropsychological testing. She stresses that ADHD symptoms must date back to childhood and impact multiple life areas, distinguishing it from general concentration issues caused by stress, sleep problems, or substance use. Non-pharmacological treatments include behavior therapy, parent training, cognitive behavioral therapy, coaching for organizational skills, social skills training, team sports, good sleep, nutrition, and school accommodations like IEPs or 504 plans.
Dr. Rea details pharmacological treatments, highlighting stimulants like Adderall and Ritalin as the 'gold standard' due to their efficacy. She differentiates between short-acting and long-acting formulations and explains how these medications work by normalizing dopamine and norepinephrine levels. Common side effects, cardiac risks, and abuse potential are discussed. She clarifies that stimulants normalize brain function in those with ADHD, while leading to 'amping up' in those without. Non-stimulant options are also mentioned for specific patient groups.
Dr. Rea outlines the significant benefits of ADHD treatment, including improved educational attainment, reduced substance use, better relationships, enhanced job stability, and a lower risk of car accidents, depression, and anxiety. She then debunks common myths: ADHD is not just for kids (it can persist into adulthood), not everyone has it despite social media trends, and not all ADHD presents with hyperactivity. She also addresses the 'hyperfocus' on video games, the safety and addictiveness of medication when properly used, and refutes the idea that people with ADHD are lazy or that medication creates 'zombies.'
Dr. Rea introduces anxiety disorders, noting their commonality (19.1% of US adults, 7% of children) and genetic component. She explains that anxiety disorders involve excessive fear or anxiety that is disproportionate to the actual threat, distinguishing between fear (a fight-or-flight response) and anxiety (muscle tension, worry about future danger). Environmental factors also play a significant role.
Dr. Rea begins discussing specific anxiety disorders. She explains that while separation anxiety is normal in toddlers, it becomes a disorder when persistent and excessive, especially in older children, manifesting as worry about losing caregivers, refusal to attend school, reluctance to be alone, and nightmares. She then describes selective mutism, typically observed in children aged 3-6, where they speak normally at home but consistently fail to speak in specific social situations like school, not due to language barriers but refusal.
This section covers specific phobias, characterized by an excessive and unreasonable fear of a particular object or situation (e.g., animals, storms, needles, flying). Individuals with phobias recognize their fear is excessive but avoid the trigger, often experiencing panic. Social anxiety disorder (social phobia) is then discussed, particularly its rise post-COVID. It involves intense fear of social situations due to apprehension of being judged, scrutinized, or embarrassed, leading to avoidance of public speaking, ordering food, or asking for directions.
Dr. Rea describes panic disorder, which involves recurrent, unexpected panic attacks – sudden, intense surges of fear or discomfort that peak rapidly, typically lasting 10-15 minutes. Symptoms include racing heart, sweating, shaking, shortness of breath, choking sensations, chest pain, nausea, dizziness, and fear of losing control or dying. She explains that many sufferers end up in emergency rooms due to fear of a heart attack. Agoraphobia, often linked to panic disorder, involves intense fear and avoidance of situations (public transport, open spaces, enclosed places, crowds, being alone outside) from which escape might be difficult or help unavailable, typically lasting over six months.
The most common anxiety disorder, General Anxiety Disorder, is characterized by excessive and pervasive worry about various events or activities, occurring most days for at least six months. Symptoms include restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbances. Individuals often report feeling anxious their 'whole life' and tend to be pessimistic. Dr. Rea then explains the 'anxious brain': decreased connection between the amygdala (fear processing) and the prefrontal cortex (regulation), and a dysregulation of the HPA axis, leading to exaggerated stress responses and elevated cortisol levels. Neurotransmitters like serotonin, norepinephrine, dopamine, and GABA are also implicated.
Dr. Rea details the psychiatric evaluation process for anxiety, which includes a comprehensive history (symptoms, childhood, adulthood, fears), screening for co-occurring conditions like ADHD and depression, and reviewing medical and family history. She also discusses social history, vital signs, lab tests, and clinical observation to form an impression and treatment recommendations. She highlights the overlap between ADHD and anxiety, noting similar symptoms like impaired concentration due to dysregulation of dopamine and norepinephrine, emphasizing the need for careful differential diagnosis due to differing treatment strategies.
For anxiety, Dr. Rea endorses cognitive behavioral therapy (CBT) as an evidence-based and highly effective approach that helps individuals change negative thought patterns to improve mood and behavior. Exposure and Response Prevention (ERP) is mentioned for phobias. Other non-pharmacological methods include mindfulness, school accommodations, good sleep, nutrition, and exercise. A crucial point is limiting accommodations for anxious individuals, as avoidance worsens anxiety. Pharmacologically, SSRIs (e.g., fluoxetine, sertraline, escitalopram) are commonly used to increase serotonin, while benzodiazepines (e.g., clonazepam, alprazolam) are used cautiously due to their addictive potential.
Treatment for anxiety leads to improved functioning, reduced fear and avoidance, increased energy, better sleep, improved attention and mental clarity, and a decreased risk of depression and substance use. Dr. Rea emphasizes that therapy combined with medication yields the best, most lasting results. She debunks common anxiety myths: it's not 'just wanting it to go away,' it requires treatment when severe, avoidance worsens it, statements like 'you have nothing to be scared about' are unhelpful, and relying solely on medication is often insufficient. She also clarifies that most anxiety medications (SSRIs) are not addictive, and importantly, chronic marijuana use can worsen anxiety and impede treatment.
During the Q&A, Dr. Rea addresses if caffeine affects ADHD and anxiety symptoms. For ADHD, she advises against high caffeine use due to side effects, suggesting stimulants are more effective. For anxiety, she cautions against caffeine as it can worsen jitteriness and negatively impact sleep, recommending minimal intake. She also provides strategies for coping with executive dysfunction in ADHD, suggesting tools like calendars, reminders, coaching, and family support, emphasizing that while medication helps, these strategies are vital for managing symptoms when medication wears off and for addressing associated guilt and self-esteem issues.